Structure Database (LMSD)

Back

LMSD: Lipid classification search results

Fatty Acyls [FA]

LM_ID Common Name Systematic Name Species Shorthand Formula Mass
LMFA07070033 2-Hydroxymyristoylcarnitine 3-[(2-hydroxytetradecanoyl)oxy]-4-(trimethylazaniumyl)butanoate CAR 14:0;O C21H41NO5 387.298474
LMFA07070042 3-hydroxylinoleoylcarnitine 3-{[(9Z,12Z)-3-hydroxyoctadeca-9,12-dienoyl]oxy}-4-(trimethylammonio)butanoate CAR 18:2;O C25H45NO5 439.329774
LMFA07070042 3-hydroxylinoleoylcarnitine 3-{[(9Z,12Z)-3-hydroxyoctadeca-9,12-dienoyl]oxy}-4-(trimethylammonio)butanoate CAR 18:2;O C25H45NO5 439.329774
LMFA07070042 3-hydroxylinoleoylcarnitine 3-{[(9Z,12Z)-3-hydroxyoctadeca-9,12-dienoyl]oxy}-4-(trimethylammonio)butanoate CAR 18:2;O C25H45NO5 439.329774
LMFA07011011 Rhodinyl butyrate 3,7-dimethyloct-7-en-1-yl butanoate SFE 14:1 C14H26O2 226.193280
LMFA07011011 Rhodinyl butyrate 3,7-dimethyloct-7-en-1-yl butanoate SFE 14:1 C14H26O2 226.193280
LMFA07011011 Rhodinyl butyrate 3,7-dimethyloct-7-en-1-yl butanoate SFE 14:1 C14H26O2 226.193280
LMFA07010965 methyl oleate methyl (9Z)-octadec-9-enoate SFE 19:1 C19H36O2 296.271531
LMFA07010965 methyl oleate methyl (9Z)-octadec-9-enoate SFE 19:1 C19H36O2 296.271531
LMFA07010954 Methyl 4-pentenoate methyl pent-4-enoate SFE 6:1 C6H10O2 114.068080
LMFA07010954 Methyl 4-pentenoate methyl pent-4-enoate SFE 6:1 C6H10O2 114.068080
LMFA07050399 Valproyl-CoA {[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[hydroxy({[hydroxy(3-hydroxy-2,2-dimethyl-3-{[2-({2-[(2-propylpentanoyl)sulfanyl]ethyl}carbamoyl)ethyl]carbamoyl}propoxy)phosphoryl]oxy})phosphoryl]oxy}methyl)oxolan-3-yl]oxy}phosphonic acid CoA 8:0 C29H50N7O17P3S 893.219674
LMFA07050399 Valproyl-CoA {[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[hydroxy({[hydroxy(3-hydroxy-2,2-dimethyl-3-{[2-({2-[(2-propylpentanoyl)sulfanyl]ethyl}carbamoyl)ethyl]carbamoyl}propoxy)phosphoryl]oxy})phosphoryl]oxy}methyl)oxolan-3-yl]oxy}phosphonic acid CoA 8:0 C29H50N7O17P3S 893.219674
LMFA07050399 Valproyl-CoA {[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[hydroxy({[hydroxy(3-hydroxy-2,2-dimethyl-3-{[2-({2-[(2-propylpentanoyl)sulfanyl]ethyl}carbamoyl)ethyl]carbamoyl}propoxy)phosphoryl]oxy})phosphoryl]oxy}methyl)oxolan-3-yl]oxy}phosphonic acid CoA 8:0 C29H50N7O17P3S 893.219674
LMFA07050399 Valproyl-CoA {[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[hydroxy({[hydroxy(3-hydroxy-2,2-dimethyl-3-{[2-({2-[(2-propylpentanoyl)sulfanyl]ethyl}carbamoyl)ethyl]carbamoyl}propoxy)phosphoryl]oxy})phosphoryl]oxy}methyl)oxolan-3-yl]oxy}phosphonic acid CoA 8:0 C29H50N7O17P3S 893.219674
LMFA07050399 Valproyl-CoA {[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[hydroxy({[hydroxy(3-hydroxy-2,2-dimethyl-3-{[2-({2-[(2-propylpentanoyl)sulfanyl]ethyl}carbamoyl)ethyl]carbamoyl}propoxy)phosphoryl]oxy})phosphoryl]oxy}methyl)oxolan-3-yl]oxy}phosphonic acid CoA 8:0 C29H50N7O17P3S 893.219674
LMFA07050399 Valproyl-CoA {[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[hydroxy({[hydroxy(3-hydroxy-2,2-dimethyl-3-{[2-({2-[(2-propylpentanoyl)sulfanyl]ethyl}carbamoyl)ethyl]carbamoyl}propoxy)phosphoryl]oxy})phosphoryl]oxy}methyl)oxolan-3-yl]oxy}phosphonic acid CoA 8:0 C29H50N7O17P3S 893.219674
LMFA02030026 ent-9-B1-PhytoP (R,E)-11-(2-ethyl-5-oxocyclopent-1-en-1-yl)-9-hydroxyundec-10-enoic acid FA 18:4;O2 C18H28O4 308.198761
LMFA04020371 (10R,13R,16R)-d11-14-NeuroF[14S,17R] (4Z,7Z,10R,11E,13R)-10,13-dihydroxy-13-((2S,4R,5R)-4-hydroxy-5-((Z)-pent-2-en-1-yl)tetrahydrofuran-2-yl)trideca-4,7,11-trienoic acid FA 22:5;O4 C22H34O6 394.235541
LMFA01140107 Alutacenoic acid A 6-(3-oxocyclopropen-1-yl)hexanoic acid FA 9:3;O C9H12O3 168.078645
LMFA01140107 Alutacenoic acid A 6-(3-oxocyclopropen-1-yl)hexanoic acid FA 9:3;O C9H12O3 168.078645
LMFA01140107 Alutacenoic acid A 6-(3-oxocyclopropen-1-yl)hexanoic acid FA 9:3;O C9H12O3 168.078645
LMFA01140108 Alutacenoic acid B 8-(3-oxocyclopropen-1-yl)octanoic acid FA 11:3;O C11H16O3 196.109945
LMFA01140108 Alutacenoic acid B 8-(3-oxocyclopropen-1-yl)octanoic acid FA 11:3;O C11H16O3 196.109945
LMFA01140108 Alutacenoic acid B 8-(3-oxocyclopropen-1-yl)octanoic acid FA 11:3;O C11H16O3 196.109945
LMFA04010170 7-D4t-NeuroP (S,4Z,8E)-7-hydroxy-9-((1S,2R,5S)-5-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-3-oxocyclopentyl)nona-4,8-dienoic acid FA 22:6;O3 C22H32O5 376.224976
LMFA02000296 Ixoric acid 8Z,10Z,12Z,14E-octadecatetraenoic acid FA 18:4 C18H28O2 276.208930
LMFA02000296 Ixoric acid 8Z,10Z,12Z,14E-octadecatetraenoic acid FA 18:4 C18H28O2 276.208930
LMFA01070023 13,14-epoxy-7Z,10Z-Hexadecenoic acid 13,14-epoxy-7Z,10Z-Hexadecenoic acid FA 16:3;O C16H26O3 266.188195
LMFA01070023 13,14-epoxy-7Z,10Z-Hexadecenoic acid 13,14-epoxy-7Z,10Z-Hexadecenoic acid FA 16:3;O C16H26O3 266.188195
LMFA01050541 8-Hydroxypalmitic acid 8-Hydroxyhexadecanoic acid FA 16:0;O C16H32O3 272.235146
LMFA08010031 11-hydroxy-11-methyldodecanamide NA 13:0;O C13H27NO2 229.204179
LMFA02000310 12-Keto-9Z,13Z,15Z-octadecatrienoic acid 12-Oxo-9Z,13Z,15Z-octadecatrienoic acid FA 18:4;O C18H28O3 292.203846
LMFA02000310 12-Keto-9Z,13Z,15Z-octadecatrienoic acid 12-Oxo-9Z,13Z,15Z-octadecatrienoic acid FA 18:4;O C18H28O3 292.203846
LMFA02000310 12-Keto-9Z,13Z,15Z-octadecatrienoic acid 12-Oxo-9Z,13Z,15Z-octadecatrienoic acid FA 18:4;O C18H28O3 292.203846
LMFA01050551 5-Acetoxy-tetradeca-2E,4E,6E-trienoic acid 5-Acetoxy-2E,4E,6E-tetradecatrienoic acid FA 16:4;O2 C16H24O4 280.167460
LMFA01050551 5-Acetoxy-tetradeca-2E,4E,6E-trienoic acid 5-Acetoxy-2E,4E,6E-tetradecatrienoic acid FA 16:4;O2 C16H24O4 280.167460
LMFA04020049 (13R,16R,20R)-d18-14-NeuroF[14R,17R] (R,4Z,7Z,10Z)-13-hydroxy-13-((2R,4R,5R)-4-hydroxy-5-((R,E)-3-hydroxypent-1-en-1-yl)tetrahydrofuran-2-yl)trideca-4,7,10-trienoic acid FA 22:5;O4 C22H34O6 394.235541
LMFA04020137 (10S,14S,17R)-d11-13-NeuroF[13S,16S] (S,4Z,7Z,11E)-10-hydroxy-12-((2S,3S,5S)-3-hydroxy-5-((R,Z)-1-hydroxyhex-3-en-1-yl)tetrahydrofuran-2-yl)dodeca-4,7,11-trienoic acid FA 22:5;O4 C22H34O6 394.235541
LMFA04020141 (10S,14S,17S)-d11-13-NeuroF[13S,16S] (S,4Z,7Z,11E)-10-hydroxy-12-((2S,3S,5S)-3-hydroxy-5-((S,Z)-1-hydroxyhex-3-en-1-yl)tetrahydrofuran-2-yl)dodeca-4,7,11-trienoic acid FA 22:5;O4 C22H34O6 394.235541
LMFA04020211 (4R,7R,11R)-d9-5-NeuroF[5S,8R] (R)-4-hydroxy-4-((2S,4R,5R)-4-hydroxy-5-((R,1E,5Z,8Z,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)tetrahydrofuran-2-yl)butanoic acid FA 22:5;O4 C22H34O6 394.235541
LMFA04020298 (14S,17S,20R)-d18-13-NeuroF[13S,16R] (4Z,7Z,10Z)-12-((2S,3S,5R)-5-((1S,4R,E)-1,4-dihydroxyhex-2-en-1-yl)-3-hydroxytetrahydrofuran-2-yl)dodeca-4,7,10-trienoic acid FA 22:5;O4 C22H34O6 394.235541
LMFA04020434 (7R,10R,13R)-d8-11-NeuroF[11R,14S] (4Z,7R,8E,10R)-7,10-dihydroxy-10-((2R,4R,5S)-4-hydroxy-5-((2Z,5Z)-octa-2,5-dien-1-yl)tetrahydrofuran-2-yl)deca-4,8-dienoic acid FA 22:5;O4 C22H34O6 394.235541
LMFA04020438 (7R,10R,13S)-d8-11-NeuroF[11R,14S] (4Z,7R,8E,10R)-7,10-dihydroxy-10-((2R,4S,5S)-4-hydroxy-5-((2Z,5Z)-octa-2,5-dien-1-yl)tetrahydrofuran-2-yl)deca-4,8-dienoic acid FA 22:5;O4 C22H34O6 394.235541
LMFA04020487 (5S,8R,11S)-d9-4-NeuroF[4R,7S] 3-((2R,3S,5S)-5-((1R,2E,4S,6Z,9Z,12Z)-1,4-dihydroxypentadeca-2,6,9,12-tetraen-1-yl)-3-hydroxytetrahydrofuran-2-yl)propanoic acid FA 22:5;O4 C22H34O6 394.235541
LMFA04020489 (5S,8S,11R)-d9-4-NeuroF[4S,7S] 3-((2S,3S,5S)-5-((1S,2E,4R,6Z,9Z,12Z)-1,4-dihydroxypentadeca-2,6,9,12-tetraen-1-yl)-3-hydroxytetrahydrofuran-2-yl)propanoic acid FA 22:5;O4 C22H34O6 394.235541
LMFA01150068 3-carboxy-4-methyl-5-(4-hydroxypentyl)-2-furanpropanoic acid 3-carboxy-4-methyl-5-(4-hydroxypentyl)-2-furanpropanoic acid FA 14:4;O4 C14H20O6 284.125990
LMFA01150068 3-carboxy-4-methyl-5-(4-hydroxypentyl)-2-furanpropanoic acid 3-carboxy-4-methyl-5-(4-hydroxypentyl)-2-furanpropanoic acid FA 14:4;O4 C14H20O6 284.125990
LMFA01150068 3-carboxy-4-methyl-5-(4-hydroxypentyl)-2-furanpropanoic acid 3-carboxy-4-methyl-5-(4-hydroxypentyl)-2-furanpropanoic acid FA 14:4;O4 C14H20O6 284.125990
LMFA01150068 3-carboxy-4-methyl-5-(4-hydroxypentyl)-2-furanpropanoic acid 3-carboxy-4-methyl-5-(4-hydroxypentyl)-2-furanpropanoic acid FA 14:4;O4 C14H20O6 284.125990